https://www.cidrap.umn.edu/news-perspective/2022/10/stewardship-resistance-scan-oct-18-2022
Stewardship / Resistance Scan for Oct 18, 2022
Ambulatory care antibiotic prescribing toolkit;
New funding for GARDP
Filed Under:
Antimicrobial Stewardship
New toolkit aims to improve ambulatory antibiotic prescribing
The US Agency for Healthcare Research and Quality (AHRQ) yesterday released a new toolkit to help hospitals improve antibiotic use in ambulatory care.
Centered around AHRQ's Four Moments of Antibiotic Decision Making framework, the toolkit aims to improve antibiotic prescribing in settings like doctor's offices and urgent care clinics—where most antibiotics are prescribed and where unnecessary antibiotic use is common—using online presentations, guidelines, and other educational tools. The focus is on helping ambulatory care practices develop and strengthen their antibiotic stewardship infrastructure, providing strategies for communicating with patients about antibiotic prescribing, and teaching best practices for diagnosing and managing common infectious syndromes.
The toolkit is based on an AHRQ Safety Program rolled out at primary care, urgent care, pediatric care, and other US ambulatory clinics in December 2019.
In a paper published in JAMA Network Open in July, researchers found that the program was associated with a 9% absolute decrease in antibiotic prescribing from December 2019 through November 20202 in 389 clinics that participated in the program. The study also found that participating clinics showed improvements in the infrastructure needed to maintain antibiotic stewardship programs.
Oct 18 AHRQ ambulatory care toolkit
Jul 12 CIDRAP News story
GARDP receives additional funding from Germany
The German government announced yesterday that it will provide €50 million ($49.15 million US) in funding over 5 years to the Global Antibiotic Research and Development Partnership (GARDP) to develop treatments for drug-resistant infections.
The money from the German Federal Ministry of Education and Research, which was announced at the World Health Summit in Berlin, brings the total German contribution to GARDP to €116 million since 2016.
"We are deeply grateful to Germany for its renewed investment in GARDP, which characterizes their remarkable leadership in global health and efforts to tackle the existing pandemic of antibiotic resistance," GARDP Executive Director Manica Balasegaram, MRCP, MSc, said in a press release. "Germany's contribution recognizes that effective antibiotics are the foundation of modern medicine. Without them, routine surgery, childbirth, and chemotherapy will no longer be safe, and common infections will no longer be treatable."
GARDP has also received recent funding from the governments of Monaco and Canada to address neonatal sepsis in Africa and further develop an initiative to provide antibiotic access to countries in need.
Oct 17 GARDP press release
Stewardship / Resistance Scan for Oct 18, 2022
Ambulatory care antibiotic prescribing toolkit;
New funding for GARDP
Filed Under:
Antimicrobial Stewardship
New toolkit aims to improve ambulatory antibiotic prescribing
The US Agency for Healthcare Research and Quality (AHRQ) yesterday released a new toolkit to help hospitals improve antibiotic use in ambulatory care.
Centered around AHRQ's Four Moments of Antibiotic Decision Making framework, the toolkit aims to improve antibiotic prescribing in settings like doctor's offices and urgent care clinics—where most antibiotics are prescribed and where unnecessary antibiotic use is common—using online presentations, guidelines, and other educational tools. The focus is on helping ambulatory care practices develop and strengthen their antibiotic stewardship infrastructure, providing strategies for communicating with patients about antibiotic prescribing, and teaching best practices for diagnosing and managing common infectious syndromes.
The toolkit is based on an AHRQ Safety Program rolled out at primary care, urgent care, pediatric care, and other US ambulatory clinics in December 2019.
In a paper published in JAMA Network Open in July, researchers found that the program was associated with a 9% absolute decrease in antibiotic prescribing from December 2019 through November 20202 in 389 clinics that participated in the program. The study also found that participating clinics showed improvements in the infrastructure needed to maintain antibiotic stewardship programs.
Oct 18 AHRQ ambulatory care toolkit
Jul 12 CIDRAP News story
GARDP receives additional funding from Germany
The German government announced yesterday that it will provide €50 million ($49.15 million US) in funding over 5 years to the Global Antibiotic Research and Development Partnership (GARDP) to develop treatments for drug-resistant infections.
The money from the German Federal Ministry of Education and Research, which was announced at the World Health Summit in Berlin, brings the total German contribution to GARDP to €116 million since 2016.
"We are deeply grateful to Germany for its renewed investment in GARDP, which characterizes their remarkable leadership in global health and efforts to tackle the existing pandemic of antibiotic resistance," GARDP Executive Director Manica Balasegaram, MRCP, MSc, said in a press release. "Germany's contribution recognizes that effective antibiotics are the foundation of modern medicine. Without them, routine surgery, childbirth, and chemotherapy will no longer be safe, and common infections will no longer be treatable."
GARDP has also received recent funding from the governments of Monaco and Canada to address neonatal sepsis in Africa and further develop an initiative to provide antibiotic access to countries in need.
Oct 17 GARDP press release